Reuters logo
3 个月前
BRIEF-Kuros Biosciences appoints Ivan Cohen-Tanugi as CEO
2017年4月13日 / 凌晨5点07分 / 3 个月前

BRIEF-Kuros Biosciences appoints Ivan Cohen-Tanugi as CEO

1 分钟阅读

April 13 (Reuters) - Kuros Biosciences AG:

* Announces CEO succession

* Ivan Cohen-Tanugi has been appointed Chief Executive Officer with effect as of April 13, 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below